RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 84 filers reported holding RAPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $438,718 | -3.9% | 26,397 | +8.1% | 0.00% | – |
| Q2 2023 | $456,524 | +1.2% | 24,413 | -0.7% | 0.00% | – |
| Q1 2023 | $451,000 | +138243.6% | 24,589 | +49.2% | 0.00% | – |
| Q4 2022 | $326 | -99.9% | 16,486 | +0.4% | 0.00% | – |
| Q3 2022 | $395,000 | +39.6% | 16,415 | +6.1% | 0.00% | – |
| Q2 2022 | $283,000 | -5.4% | 15,469 | +14.0% | 0.00% | – |
| Q1 2022 | $299,000 | -25.8% | 13,575 | +23.7% | 0.00% | – |
| Q4 2021 | $403,000 | -28.2% | 10,976 | -39.3% | 0.00% | – |
| Q3 2021 | $561,000 | +116.6% | 18,082 | +121.6% | 0.00% | – |
| Q2 2021 | $259,000 | +178.5% | 8,159 | +95.1% | 0.00% | – |
| Q1 2021 | $93,000 | -62.9% | 4,182 | -67.1% | 0.00% | – |
| Q4 2020 | $251,000 | +11.1% | 12,700 | +54.2% | 0.00% | – |
| Q3 2020 | $226,000 | -72.8% | 8,234 | -71.2% | 0.00% | – |
| Q2 2020 | $830,000 | +7445.5% | 28,595 | +5630.5% | 0.00% | – |
| Q1 2020 | $11,000 | -21.4% | 499 | -1.6% | 0.00% | – |
| Q4 2019 | $14,000 | – | 507 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi Management, LLC | 1,599,417 | $29,189,000 | 46.08% |
| KPCB XV Associates, LLC | 1,297,063 | $23,671,000 | 43.66% |
| Column Group LLC | 2,680,458 | $48,918,000 | 10.41% |
| Ponoi II Management, LLC | 145,401 | $2,654,000 | 7.21% |
| Euclidean Capital LLC | 432,900 | $7,900,000 | 6.72% |
| AJU IB Investment Co., Ltd. | 99,503 | $1,816,000 | 3.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,023,321 | $18,676,000 | 3.17% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 443,619 | $8,096,000 | 1.62% |
| Ghost Tree Capital, LLC | 165,000 | $3,011,000 | 1.57% |
| Perceptive Advisors | 1,913,791 | $34,927,000 | 1.09% |